GR3019689T3 - Excitatory amino acid antagonists - Google Patents

Excitatory amino acid antagonists

Info

Publication number
GR3019689T3
GR3019689T3 GR960401068T GR960401068T GR3019689T3 GR 3019689 T3 GR3019689 T3 GR 3019689T3 GR 960401068 T GR960401068 T GR 960401068T GR 960401068 T GR960401068 T GR 960401068T GR 3019689 T3 GR3019689 T3 GR 3019689T3
Authority
GR
Greece
Prior art keywords
amino acid
excitatory amino
acid antagonists
antagonists
excitatory
Prior art date
Application number
GR960401068T
Other languages
Greek (el)
English (en)
Inventor
Francesco G Salituro
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of GR3019689T3 publication Critical patent/GR3019689T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR960401068T 1990-07-16 1996-04-19 Excitatory amino acid antagonists GR3019689T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55605790A 1990-07-16 1990-07-16
PCT/US1991/004253 WO1992001670A1 (en) 1990-07-16 1991-06-17 Excitatory amino acid antagonists

Publications (1)

Publication Number Publication Date
GR3019689T3 true GR3019689T3 (en) 1996-07-31

Family

ID=24219725

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401068T GR3019689T3 (en) 1990-07-16 1996-04-19 Excitatory amino acid antagonists

Country Status (15)

Country Link
US (1) US5106847A (index.php)
EP (1) EP0539503B1 (index.php)
JP (1) JP3058688B2 (index.php)
KR (1) KR0178469B1 (index.php)
AT (1) ATE136295T1 (index.php)
AU (1) AU646686B2 (index.php)
CA (1) CA2087091C (index.php)
DE (1) DE69118539T2 (index.php)
DK (1) DK0539503T3 (index.php)
ES (1) ES2088011T3 (index.php)
FI (1) FI98455C (index.php)
GR (1) GR3019689T3 (index.php)
HU (1) HU216787B (index.php)
NO (1) NO179249C (index.php)
WO (1) WO1992001670A1 (index.php)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
TW280819B (index.php) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
EP0843660A1 (en) * 1995-07-31 1998-05-27 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
HUP0000882A3 (en) * 1996-09-30 2001-04-28 Aventis Pharmaceuticals Inc Br Indole derivatives as nmda (n-methyl-d-aspartate) antagonists and pharmaceutical compositions containing them
WO1998041092A1 (en) * 1997-03-14 1998-09-24 Smithkline Beecham Corporation Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
CN103497114A (zh) * 2007-06-29 2014-01-08 埃莫里大学 用于神经保护的nmda受体拮抗剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
WO1992004321A1 (en) * 1990-09-10 1992-03-19 Rhone-Poulenc Rorer International (Holdings) Inc. Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
AU646686B2 (en) 1994-03-03
DK0539503T3 (da) 1996-05-13
NO930035D0 (no) 1993-01-07
HU216787B (hu) 1999-08-30
NO930035L (no) 1993-01-07
HU9300100D0 (en) 1993-04-28
DE69118539T2 (de) 1996-09-19
KR0178469B1 (ko) 1999-03-20
CA2087091C (en) 2001-09-11
EP0539503B1 (en) 1996-04-03
FI930150A0 (fi) 1993-01-14
DE69118539D1 (de) 1996-05-09
FI98455B (fi) 1997-03-14
FI930150L (fi) 1993-01-14
JP3058688B2 (ja) 2000-07-04
EP0539503A4 (index.php) 1994-03-23
NO179249B (no) 1996-05-28
JPH05508857A (ja) 1993-12-09
ATE136295T1 (de) 1996-04-15
AU8290891A (en) 1992-02-18
FI98455C (fi) 1997-06-25
NO179249C (no) 1996-09-04
HUT67237A (en) 1995-03-28
ES2088011T3 (es) 1996-08-01
CA2087091A1 (en) 1992-01-17
US5106847A (en) 1992-04-21
EP0539503A1 (en) 1993-05-05
WO1992001670A1 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
GR3019689T3 (en) Excitatory amino acid antagonists
ZA902928B (en) Excitatory amino acid antagonists
FI961628A7 (fi) Indolijohdannaisia NMDA-antagonisteina
HUP9801838A3 (en) Indole derivatives as antagonists of excitatory amino acids
TW207950B (index.php)
DE69108234D1 (en) 3-indolyl thioacetat derivate.
MX9801967A (es) Tetrahidroquinolinas como antagonistas de los aminoacidos excitadores (nmda).
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
AU662322B2 (en) Cholecystokinin antagonists
DE69230224D1 (de) Potenzierung von nmda-antagonisten
FI103202B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksi
ES2166545T3 (es) Procedimiento de preparacion de un aminoacido activado.